290 related articles for article (PubMed ID: 9621404)
1. Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver.
Low RN
Top Magn Reson Imaging; 1998 Jun; 9(3):141-66. PubMed ID: 9621404
[TBL] [Abstract][Full Text] [Related]
2. MR imaging of the liver using gadolinium chelates.
Low RN
Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):717-43, vi. PubMed ID: 11694435
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced magnetic resonance imaging of the abdomen.
Brown ED; Semelka RC
Magn Reson Q; 1994 Jun; 10(2):97-124. PubMed ID: 7986704
[TBL] [Abstract][Full Text] [Related]
4. Liver I: Currently available gadolinium chelates.
Mitchell DG
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):37-51. PubMed ID: 8673715
[TBL] [Abstract][Full Text] [Related]
5. MR imaging of the liver. Contrast agents.
Mahfouz AE; Hamm B
Magn Reson Imaging Clin N Am; 1997 May; 5(2):223-40. PubMed ID: 9113673
[TBL] [Abstract][Full Text] [Related]
6. Liver MRI with contrast enhancement.
Runge VM
Crit Rev Diagn Imaging; 1997 Jun; 38(3):207-30. PubMed ID: 9226107
[TBL] [Abstract][Full Text] [Related]
7. Post-processing of dynamic gadolinium-enhanced magnetic resonance imaging exams of the liver: explanation and potential clinical applications for color-coded qualitative and quantitative analysis.
Wang L; Van den Bos IC; Hussain SM; Pattynama PM; Vogel MW; Krestin GP
Acta Radiol; 2008 Feb; 49(1):6-18. PubMed ID: 18210307
[TBL] [Abstract][Full Text] [Related]
8. Contrast agents for MR imaging of the liver.
Balci NC; Semelka RC
Radiol Clin North Am; 2005 Sep; 43(5):887-98, viii. PubMed ID: 16098345
[TBL] [Abstract][Full Text] [Related]
9. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-enhanced MR imaging of liver capsule and peritoneum.
Low RN
Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):803-19, vii. PubMed ID: 11694439
[TBL] [Abstract][Full Text] [Related]
11. Role of chelates in magnetic resonance imaging studies.
Tripathi L; Kumar P; Singh R
J Cancer Res Ther; 2009; 5(3):148-53. PubMed ID: 19841554
[TBL] [Abstract][Full Text] [Related]
12. [Progress in magnetic resonance tomography of the liver: value of ultra-rapid imaging and liver-specific contrast media].
Reimer P; Rummeny EJ; Hamm B; Mühler A; Cavagna F; Saini S; Peters PE
Bildgebung; 1994 Mar; 61(1):5-13. PubMed ID: 8193519
[TBL] [Abstract][Full Text] [Related]
13. MultiHance: help or hype?
Bartolozzi C; Spinazzi A
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S151-9. PubMed ID: 10608411
[TBL] [Abstract][Full Text] [Related]
14. [VIBE with parallel acquisition technique - a novel approach to dynamic contrast-enhanced MR imaging of the liver].
Dobritz M; Radkow T; Nittka M; Bautz W; Fellner FA
Rofo; 2002 Jun; 174(6):738-41. PubMed ID: 12063604
[TBL] [Abstract][Full Text] [Related]
15. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging.
Ito K
Eur J Radiol; 2006 May; 58(2):186-99. PubMed ID: 16413154
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium-enhanced imaging of liver tumors and manifestations of hepatitis: pharmacodynamic and technical considerations.
Sharma P; Kitajima HD; Kalb B; Martin DR
Top Magn Reson Imaging; 2009 Apr; 20(2):71-8. PubMed ID: 20010061
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
[TBL] [Abstract][Full Text] [Related]
20. Pediatric liver: focal masses.
Siegel MJ; Chung EM; Conran RM
Magn Reson Imaging Clin N Am; 2008 Aug; 16(3):437-52, v. PubMed ID: 18585597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
